Humanwell Healthcare Group Stock Current Valuation

600079 Stock   19.89  0.34  1.68%   
Valuation analysis of Humanwell Healthcare helps investors to measure Humanwell Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Humanwell Healthcare's Cash is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Operating Activities is expected to grow to about 2.4 B, whereas Other Cashflows From Financing Activities is projected to grow to (118.1 M). Fundamental drivers impacting Humanwell Healthcare's valuation include:
Price Book
1.8169
Enterprise Value
37.2 B
Enterprise Value Ebitda
10.2723
Price Sales
1.2703
Trailing PE
16.7143
Overvalued
Today
19.89
Please note that Humanwell Healthcare's price fluctuation is not too volatile at this time. Calculation of the real value of Humanwell Healthcare is based on 3 months time horizon. Increasing Humanwell Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Humanwell Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Humanwell Stock. However, Humanwell Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  19.89 Real  17.77 Hype  19.93 Naive  19.67
The real value of Humanwell Stock, also known as its intrinsic value, is the underlying worth of Humanwell Healthcare Company, which is reflected in its stock price. It is based on Humanwell Healthcare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Humanwell Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
17.77
Real Value
20.04
Upside
Estimating the potential upside or downside of Humanwell Healthcare Group helps investors to forecast how Humanwell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Humanwell Healthcare more accurately as focusing exclusively on Humanwell Healthcare's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.000.000.00
Details
Hype
Prediction
LowEstimatedHigh
17.6619.9322.20
Details
Naive
Forecast
LowNext ValueHigh
17.4019.6721.93
Details

Humanwell Healthcare Group Company Current Valuation Analysis

Humanwell Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Humanwell Healthcare Current Valuation

    
  37.21 B  
Most of Humanwell Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humanwell Healthcare Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Humanwell Healthcare Group has a Current Valuation of 37.21 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.

Humanwell Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humanwell Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Humanwell Healthcare could also be used in its relative valuation, which is a method of valuing Humanwell Healthcare by comparing valuation metrics of similar companies.
Humanwell Healthcare is currently under evaluation in current valuation category among its peers.

Humanwell Fundamentals

About Humanwell Healthcare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Humanwell Healthcare Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humanwell Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humanwell Healthcare Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Humanwell Stock

Humanwell Healthcare financial ratios help investors to determine whether Humanwell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humanwell with respect to the benefits of owning Humanwell Healthcare security.